1.Design of monitoring system for physiological parameters of a crew
Hong WAN ; Yanqi WANG ; Xinbin KAO ; Jinhai YAN ; Siyuan LUO
Military Medical Sciences 2015;(9):656-659
Objective To design a monitoring system of the state of life for a crew in order to ensure their life safety. Methods A wearable physiological parameter monitoring technology was used, and the fabric electrode and temperature sensors were embedded in the vest.The thress-lead electrode was used to extract ECG and respiration signal,temperature signals were collected with a thermistor of negative temperature parameters.Blood pressure and blood oxygen saturation were detected by a finger cuff type of blood oxygen sensors.The volume pulse wave velocity method was used to extract blood pressure signals,and the photoelectric measurement method was used to extract blood oxygen saturation signals.The state of life was evaluated by calculation of the times of respiration and divided into 4 states.Results and Conclusion The system is capable of low load dynamic monitoring of physiological parameters of a crew and evaluation of their state of life, contributing much to self-aid and buddy aid among the crew.
2.Determination and clinical evaluation of serum procalcitonin in children with pneumonia.
Guo-hong ZHU ; Cai-fu WANG ; She-sheng LUO ; Yan KAO ; Zhi-min CHEN
Chinese Journal of Pediatrics 2003;41(2):147-147
C-Reactive Protein
;
analysis
;
Calcitonin
;
blood
;
Calcitonin Gene-Related Peptide
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Male
;
Pneumonia
;
blood
;
diagnosis
;
Protein Precursors
;
blood
3.The effect of shenfu injection on immune function in severe trauma patients
Limei LEI ; Xiang LAN ; Yan KAO ; Hao ZHENG ; Jie PAN ; Dingding HUANG
Chinese Journal of Primary Medicine and Pharmacy 2015;(19):2928-2930,2931
Objective To investigate the effect of shenfu injection on immune function in severe trauma patients.Methods 60 severe trauma patients were divided into the control group (n =30)and shefu group (n =30) by random number table.Other 30 cases were chosen as the health control group at the same phase.All patients were received conventional treatments,however,patients of the shenfu group were additionally received the shenfu injection treatment in the early stage.The CD +3 ,CD +4 ,CD +8 cell,human leukocyte antigen (HLA -DR),interleukin -1(IL -1),interleukin -6(IL -6)were detected on 3rd and 7th day by double -antibody sandwich enzyme -linked immu-nosorbent assay (ELISA).Results Compared to the health control group,the IL -1,IL -6 in the control and shenfu group were significantly higher than the health control group(f=7.128,q =9.212,10.112,all P <0.05).The IL -1and IL -6 in the control and shenfu group were significantly increased on 3rd day (t =11.126,10.013,all P <0.05)and decreased on 7th day(t =17.121,14.213,all P <0.05).The IL -1 and IL -6 in shenfu group were sig-nificantly lower than that of the control group(χ2 =4.113,10.117,all P <0.05).The CD +3 ,CD +4 ,CD +8 ,HLA -DR and CD +3 /CD +8 rate in the control and shenfu group were significantly lower than the health control group(f=11.071, q =10.229,12.032,all P <0.05).On 3rd day,the CD +3 ,CD +4 ,CD +8 ,HLA -DR and CD +3 /CD +8 rate in shenfu group were significantly increased(t =10.013,P <0.05).On 7th day,CD +3 ,CD +4 ,CD +8 ,HLA -DR and CD +3 /CD +8 rate in the control and shenfu group were both increased(t =11.126,15.932,all P <0.05).And the CD +3 ,CD +4 ,CD +8 ,HLA -DR and CD +3 /CD +8 rate in shenfu group were significantly higher than the control group(χ2 =3.771,P <0.05).Conclusion Shenfu injection can regulate immune function in severe trauma and improve clinical treatment.
4.Detection of serum levels of MMP-9 and VEGF in patients with bladder cancer.
Kao-peng GUAN ; Shu-kun HOU ; Zheng YAN ; Hai-yun YE
Chinese Journal of Surgery 2003;41(6):430-432
OBJECTIVETo detect serum levels of MMP-9 and VEGF in patients with bladder cancer.
METHODSSerum levels of MMP-9 and VEGF in 58 patients with bladder cancer and 45 healthy controls were measured by sandwich-ELISA.
RESULTSSerum levels of MMP-9 and VEGF (737.12 micro g/L and 1148.88 ng/L) were significantly higher in the cancer patients than those of controls (423.51 micro g/L and 846.96 ng/L, P < 0.01). The serum levels were associated with tumor stage and grade. In patients with invasive cancer, the levels were significantly higher than those of superficial cancer (P < 0.01). Patients with distant metastasis had significantly higher levels of MMP-9 and VEGF than those with localized invasion (P < 0.01). But there was no significant difference between patients with superficial cancer and controls. Patients with G(3) tumors had significantly higher levels of MMP-9 and VEGF than those of patients with G(1) and G(2) tumors (P < 0.01).
CONCLUSIONSElevated MMP-9 and VEGF levels are associated with a high stage and grade of bladder cancer and they may serve as markers of tumor progression in the future.
Aged ; Humans ; Matrix Metalloproteinase 9 ; blood ; Middle Aged ; Neoplasm Staging ; Urinary Bladder Neoplasms ; blood ; pathology ; Vascular Endothelial Growth Factor A ; blood
5.Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions
Ya GAO ; Xiao-Ni ZHONG ; Yan-Hong YANG ; Kao-Cong TIAN
Chinese Journal of Cardiology 2012;40(5):432-435
Objective To examine the plasma lipid level and distribution of dyslipidemia in workers of Chongqing enterprises and institutions.Methods By using cluster sampling method,20 000 workers of Chongqing enterprises and institutions aged 18 to 60 were selected as target population from January to October,2009.We conducted questionnaire survey,physical and laboratory examinations including total cholesterol ( TC ),triglyceride ( TG ),high-density lipoprotein cholesterol ( HDL-C ) and low-density lipoprotein cholesterol (LDL-C).Workers were divided into 18 -29 years old group,30 -39 years old group,40 -49 years old group and 50 -60 years old group.Characteristic and distribution of dyslipidemia were analyzed.Results Total cholesterol ( TC ),triglyceride ( TG),high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol( LDL-C ) were significantly different in various age group (all P <0.01 ).TC,TG,HDL-C and LDL-C levels in the 30 years and over groups were all significantly higher than in the under 30 years old group( all P < 0.01 ).The TG levels in the 40 -49 years old group and the 50- 60 years old group were similar( P > 0.05 ).After adjusting for age,TC,TG,HDL-C and LDL-C levels in males were all significantly higher than in females( all P <0.01 ).The incidence of dyslipidemia in this population was 35.01% and significantly higher in males than that of females ( 58.27% vs.11.01%,P <0.01 ).The incidence of dyslipidemia increased with aging( P <0.01 ).Conclusions The prevalence of dyslipidemia is high in Chongqing enterprises and institutions.The incidence of dyslipidemia is higher in males than in females and higher among the 30 years and over workers than that of under 30 years old workers.
6.Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells.
Shu-Qin WEI ; Li-Hua SUI ; Jian-Hua ZHENG ; Guang-Mei ZHANG ; Yan-Lin KAO
Chinese Medical Sciences Journal 2004;19(2):125-129
OBJECTIVETo investigate the role of extracellular regulated kinase (ERK1/2) pathway in cisplatin-induced apoptosis in human ovarian carcinoma cells.
METHODSCisplatin-induced apoptosis were stained with DAPI and was assessed microscopically in human epithelial adenocarcinoma ovarian cell line SKOV3 cells. ERK activation was determined by Western blotting using an anti-phospho-ERK antibody to detect ERK activity. The effect of PD98059 on ERK activity induced by cisplatin was detected by MTT assay.
RESULTSMarked apoptosis of SKOV3 cells resulted from 48 hours treatment with 20 microg/mL cisplatin. Strong activation of ERK was led to by 15 microg/mL cisplatin. Dose response and time course of cisplatin induced apoptosis in SKOV3 cells. Cisplatin-induced ERK activation occurred at 12 hours and increased to highest induction at 24 hours by Western blotting. The effect of PD 98059 on ERK activity induced by cisplatin at the concentration of 100 micromol/L PD 98059. Statistically significant decreased in cell survival were observed with 100 micromol/L PD 98059 at 15 and 20 microg/mL cisplatin (P < 0.05).
CONCLUSIONSCisplatin activates the ERK signaling pathway in ovarian cancer cell line SKOV3. Inhibition of ERK activity enhances sensitivity to cisplatin cytotoxity in ovarian cancer cell line SKOV3. Evaluation of ERK activity could be useful in predicting which ovarian cancer will response most favorably to cisplatin therapy.
Adenocarcinoma ; enzymology ; pathology ; Antineoplastic Agents ; pharmacology ; Apoptosis ; drug effects ; Cell Line, Tumor ; Cell Survival ; drug effects ; Cisplatin ; pharmacology ; Enzyme Activation ; drug effects ; Female ; Flavonoids ; pharmacology ; Humans ; Mitogen-Activated Protein Kinase 3 ; Mitogen-Activated Protein Kinases ; metabolism ; Ovarian Neoplasms ; enzymology ; pathology ; Signal Transduction
7.Analysis of lung function in children with respiratory diseases and its clinical application.
Yi-fang CHEN ; Yan KAO ; Xue-ying XIN ; Ke-wen JIANG
Journal of Zhejiang University. Medical sciences 2005;34(4):365-367
OBJECTIVETo evaluate the clinical application of lung function analysis in diagnosis of children respiratory diseases.
METHODSRespiratory function was evaluated with portable lung function detector in 6 261 children with respiratory diseases. FEV1, FVC and PEFR were measured in 268 children with cough variant asthma (CVA) and 147 children with asthma (AS), and the results were self-compared during follow-up.
RESULTThere were no significant differences in above parameters between children with cough variant asthma and those with asthma (P>0.05). Lung functions of asthma children were improved evidently by administration of glycocorticoid inhalator (P<0.001).
CONCLUSIONLung function detection is essential for diagnosis of asthma and it can be used as a reliable index for therapeutic effect of asthma children.
Adolescent ; Asthma ; physiopathology ; Child ; Female ; Follow-Up Studies ; Humans ; Male ; Respiration ; Respiratory Function Tests
8.HIV nucleic acid results and follow-up of 73 WB negative and indeterminate samples in Dujiangyan area
Lingzhi YANG ; Mao HUANG ; Kao WANG ; Zhuona DENG ; Yan WANG ; Tao YIN ; Lijun MENG
Chinese Journal of Laboratory Medicine 2022;45(11):1150-1154
Objective:To test the HIV virus nucleic acid using immunoblot method (Western blotting, WB) and to follow-up with the negative and indeterminate samples in the Dujiangyan area, compare the WB and nucleic acid results before and after followed-up, and try to reduce the WB band′s false-negatives and false-positives.Methods:The 286 suspected HIV infection samples in the Dujiangyan region from January to October 2021 were confirmed by WB, the HIV virus load were tested for the samples that were WB negative and WB indeterminate, those patients were followed-up with epidemiological history and viral load results, and the results before and after tracking were compared.Results:In the 286 samples of suspected HIV infection included in this study, we reported 213 (74.48%) WB positive, 37 WB negative (12.94%), and 36 WB indeterminate (12.58%); 10 of 37 WB negative samples were followed-up; 18 of 36 WB indeterminate samples were followed-up. Among the followed-up WB negative and indeterminate samples, 17 of them had virus nucleic acid detection prior to the follow-up, and all of them turned positive after following-up. The others with no previous virus nucleic acid detection were confirmed to be negative.Conclusions:Among the followed-up samples, 2 samples were false-negative in WB negative results, and 3 were false-positive in WB indeterminate results. The viral nucleic acid must be tested and followed-up in WB negative and indeterminate samples.
10.Enhanced sensitivity to mitomycin C by abating heat shock protein 70 expression in human bladder cancer cell line of BIU-87.
Ling-feng HE ; Kao-peng GUAN ; Zheng YAN ; Hai-yun YE ; Ke-xin XU ; Liang REN ; Shu-kun HOU
Chinese Medical Journal 2005;118(23):1965-1972
BACKGROUNDBladder cancer is a relatively common tumor in the urinary system, in which mitomycin C (MMC)-based chemotherapy or combination chemotherapy has been mainly used to treat patients with advanced bladder cancer. The prognosis of patients with advanced bladder cancer is still extremely poor in spite of recent therapeutic advances. To improve the prognosis, the sensitivity of tumor cells to mitomycin C by the induction of apoptosis with the abating heat shock protein 70 (HSP70) expression in human bladder cancer cell lines of BIU-87 was investigated.
METHODSHSP70 expression was abated in BIU-87 cells by HSP mRNA antisense oligomers. MTT assay and the clone-forming test were used for evaluating the sensitivity of cells to MMC. Apoptosis was assessed using both fluorescent microscopy after staining the cells with Hoechst 33258 and DNA fragment ladder agarose electrophoresis. Thirty-two male six-week-old BALB/c nude mice, at the beginning of the experiment, were used to evaluate the effect of antisense oligomers (ASO) on the tumor formation in vivo.
RESULTSHSP70 expression in BIU-87 was effectively abated by HSP70 mRNA antisense oligomers. The percentage of apoptotic cells in ASO group was greater than in sense oligomers (SO) [P < 0.05, (18.31 +/- 2.89)% vs (1.89 +/- 0.74)%], nonsense oligomers (NO) [P < 0.05, (18.31 +/- 2.89)% vs (1.78 +/- 0.92)%] and blank groups [P < 0.05, (18.31 +/- 2.89)% vs (1.87 +/- 0.84)%], while the sensitivity of tumor cells to mitomycin C was enhanced. The in vivo tumor inhibition rate of ASO plus MMC (> 50%) was more than that of ASO or MMC group alone (all P < 0.05).
CONCLUSIONSThe abating level of HSP70 expression can strengthen the sensitivity of BIU-87 to MMC. One of this effect might be related to the induction of apoptosis by abating HSP70 expression.
Apoptosis ; drug effects ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; drug effects ; HSP70 Heat-Shock Proteins ; antagonists & inhibitors ; genetics ; physiology ; Humans ; Mitomycin ; pharmacology ; Oligodeoxyribonucleotides, Antisense ; pharmacology ; RNA, Messenger ; analysis ; Urinary Bladder Neoplasms ; drug therapy ; metabolism ; pathology